Fidelity International’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Fidelity International's BBIO Position: Q3 2026 in Review
Fidelity International increased its BridgeBio Pharma (BBIO) stake by 2.7% in Q3 2026, buying an estimated $2.13M and bringing the position to 1,029,673 shares worth $67.8M. The position accounts for 0.05% of the portfolio, ranked #294.
Fidelity International first reported a position in BBIO in Q2 2019 and has held it in 4 quarters since. The position peaked at $74.6M in Q2 2026. 471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- Fidelity International held 1,029,673 shares of BridgeBio Pharma worth $67.8M as of Q3 2026.
- Fidelity International bought 27,413 BridgeBio Pharma shares in Q3 2026, an estimated $2.13M.
- BridgeBio Pharma made up 0.05% of Fidelity International's portfolio in Q3 2026, its #294 holding.
- Fidelity International first reported a position in BridgeBio Pharma in Q2 2019 and has held it in 4 quarters since.
- Fidelity International's BridgeBio Pharma position peaked at $74.6M in Q2 2026.
- 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on Fidelity International's 13F filing for Q3 2026, filed 10 Nov 2026.